nodes	percent_of_prediction	percent_of_DWPC	metapath
Vidarabine—ADA—hypertension	0.484	1	CbGaD
Vidarabine—DPP4—Atorvastatin—hypertension	0.175	1	CbGbCtD
Vidarabine—ADK—Pitavastatin—Atorvastatin—hypertension	0.00249	1	CbGdCrCtD
Vidarabine—DPP4—blood vessel—hypertension	0.00212	0.06	CbGeAlD
Vidarabine—ADK—cardiac ventricle—hypertension	0.00158	0.0445	CbGeAlD
Vidarabine—ADK—myocardium—hypertension	0.00148	0.0419	CbGeAlD
Vidarabine—ADA—heart—hypertension	0.00127	0.0358	CbGeAlD
Vidarabine—ADA—decidua—hypertension	0.00123	0.0348	CbGeAlD
Vidarabine—ADA—cardiovascular system—hypertension	0.0012	0.0338	CbGeAlD
Vidarabine—ADORA2A—cardiovascular system—hypertension	0.00109	0.0307	CbGeAlD
Vidarabine—ADK—nephron tubule—hypertension	0.00109	0.0307	CbGeAlD
Vidarabine—ADK—adrenal cortex—hypertension	0.00107	0.0302	CbGeAlD
Vidarabine—DPP4—nephron tubule—hypertension	0.00105	0.0298	CbGeAlD
Vidarabine—ADK—heart—hypertension	0.00104	0.0292	CbGeAlD
Vidarabine—ADK—smooth muscle tissue—hypertension	0.00103	0.029	CbGeAlD
Vidarabine—ADK—decidua—hypertension	0.00101	0.0284	CbGeAlD
Vidarabine—DPP4—heart—hypertension	0.001	0.0284	CbGeAlD
Vidarabine—DPP4—smooth muscle tissue—hypertension	0.000996	0.0281	CbGeAlD
Vidarabine—ADK—cardiovascular system—hypertension	0.000977	0.0276	CbGeAlD
Vidarabine—DPP4—decidua—hypertension	0.000976	0.0276	CbGeAlD
Vidarabine—ADK—kidney—hypertension	0.000956	0.027	CbGeAlD
Vidarabine—DPP4—cardiovascular system—hypertension	0.000947	0.0268	CbGeAlD
Vidarabine—ADA—adrenal gland—hypertension	0.000946	0.0267	CbGeAlD
Vidarabine—ADK—cortex of kidney—hypertension	0.000931	0.0263	CbGeAlD
Vidarabine—DPP4—kidney—hypertension	0.000927	0.0262	CbGeAlD
Vidarabine—Pentostatin—ADA—hypertension	0.000911	0.188	CrCbGaD
Vidarabine—DPP4—cortex of kidney—hypertension	0.000903	0.0255	CbGeAlD
Vidarabine—ADK—cardiac atrium—hypertension	0.000886	0.025	CbGeAlD
Vidarabine—ADORA2A—adrenal gland—hypertension	0.000861	0.0243	CbGeAlD
Vidarabine—ADK—medulla oblongata—hypertension	0.000835	0.0236	CbGeAlD
Vidarabine—ADA—endocrine gland—hypertension	0.00082	0.0232	CbGeAlD
Vidarabine—ADK—adrenal gland—hypertension	0.000773	0.0218	CbGeAlD
Vidarabine—DPP4—adrenal gland—hypertension	0.000749	0.0212	CbGeAlD
Vidarabine—ADORA2A—endocrine gland—hypertension	0.000746	0.0211	CbGeAlD
Vidarabine—ADA—central nervous system—hypertension	0.000739	0.0209	CbGeAlD
Vidarabine—Adenosine triphosphate—ACVRL1—hypertension	0.000704	0.146	CrCbGaD
Vidarabine—ADORA2A—central nervous system—hypertension	0.000672	0.019	CbGeAlD
Vidarabine—ADK—endocrine gland—hypertension	0.00067	0.0189	CbGeAlD
Vidarabine—DPP4—endocrine gland—hypertension	0.00065	0.0184	CbGeAlD
Vidarabine—ADK—central nervous system—hypertension	0.000604	0.0171	CbGeAlD
Vidarabine—DPP4—central nervous system—hypertension	0.000586	0.0165	CbGeAlD
Vidarabine—S-Adenosylmethionine—CBS—hypertension	0.000557	0.115	CrCbGaD
Vidarabine—Nelarabine—ADA—hypertension	0.000439	0.0907	CrCbGaD
Vidarabine—Adenosine—ADA—hypertension	0.000332	0.0688	CrCbGaD
Vidarabine—Adenosine—ADORA1—hypertension	0.000315	0.0652	CrCbGaD
Vidarabine—Adenosine triphosphate—ADRBK1—hypertension	0.000292	0.0605	CrCbGaD
Vidarabine—Adenosine triphosphate—ABCC9—hypertension	0.000292	0.0605	CrCbGaD
Vidarabine—Glucosamine—MMP9—hypertension	0.000225	0.0466	CrCbGaD
Vidarabine—S-Adenosylmethionine—COMT—hypertension	0.000168	0.0347	CrCbGaD
Vidarabine—Adenosine monophosphate—PDE4D—hypertension	0.000164	0.0338	CrCbGaD
Vidarabine—Glucosamine—TNF—hypertension	0.000148	0.0306	CrCbGaD
Vidarabine—Adenosine triphosphate—AKT1—hypertension	0.000145	0.03	CrCbGaD
Vidarabine—Adenosine monophosphate—SRC—hypertension	0.000143	0.0296	CrCbGaD
Vidarabine—Cough—Ramipril—hypertension	3.82e-05	0.000184	CcSEcCtD
Vidarabine—Dizziness—Carvedilol—hypertension	3.81e-05	0.000184	CcSEcCtD
Vidarabine—Dyspnoea—Betaxolol—hypertension	3.81e-05	0.000184	CcSEcCtD
Vidarabine—Urticaria—Trandolapril—hypertension	3.8e-05	0.000183	CcSEcCtD
Vidarabine—Pain—Perindopril—hypertension	3.8e-05	0.000183	CcSEcCtD
Vidarabine—Musculoskeletal discomfort—Losartan—hypertension	3.8e-05	0.000183	CcSEcCtD
Vidarabine—Hypersensitivity—Valsartan—hypertension	3.8e-05	0.000183	CcSEcCtD
Vidarabine—Rash—Propranolol—hypertension	3.79e-05	0.000183	CcSEcCtD
Vidarabine—Convulsion—Ramipril—hypertension	3.79e-05	0.000183	CcSEcCtD
Vidarabine—Urticaria—Enalapril—hypertension	3.79e-05	0.000183	CcSEcCtD
Vidarabine—Dermatitis—Propranolol—hypertension	3.79e-05	0.000183	CcSEcCtD
Vidarabine—Pain—Irbesartan—hypertension	3.79e-05	0.000183	CcSEcCtD
Vidarabine—Palpitations—Timolol—hypertension	3.78e-05	0.000182	CcSEcCtD
Vidarabine—Dizziness—Doxazosin—hypertension	3.77e-05	0.000182	CcSEcCtD
Vidarabine—Loss of consciousness—Timolol—hypertension	3.76e-05	0.000181	CcSEcCtD
Vidarabine—Pain—Hydrochlorothiazide—hypertension	3.75e-05	0.000181	CcSEcCtD
Vidarabine—Vision blurred—Lisinopril—hypertension	3.74e-05	0.00018	CcSEcCtD
Vidarabine—Paraesthesia—Losartan—hypertension	3.74e-05	0.00018	CcSEcCtD
Vidarabine—Urticaria—Telmisartan—hypertension	3.74e-05	0.00018	CcSEcCtD
Vidarabine—Cough—Timolol—hypertension	3.73e-05	0.00018	CcSEcCtD
Vidarabine—Chest pain—Ramipril—hypertension	3.73e-05	0.00018	CcSEcCtD
Vidarabine—Dizziness—Fosinopril—hypertension	3.72e-05	0.00018	CcSEcCtD
Vidarabine—Tremor—Lisinopril—hypertension	3.72e-05	0.000179	CcSEcCtD
Vidarabine—Dyspnoea—Losartan—hypertension	3.71e-05	0.000179	CcSEcCtD
Vidarabine—Anxiety—Ramipril—hypertension	3.71e-05	0.000179	CcSEcCtD
Vidarabine—Somnolence—Losartan—hypertension	3.7e-05	0.000179	CcSEcCtD
Vidarabine—Dizziness—Eplerenone—hypertension	3.7e-05	0.000179	CcSEcCtD
Vidarabine—Vomiting—Indapamide—hypertension	3.7e-05	0.000179	CcSEcCtD
Vidarabine—Vomiting—Diltiazem—hypertension	3.7e-05	0.000179	CcSEcCtD
Vidarabine—Asthenia—Valsartan—hypertension	3.7e-05	0.000178	CcSEcCtD
Vidarabine—Hypertension—Timolol—hypertension	3.69e-05	0.000178	CcSEcCtD
Vidarabine—Pain—Furosemide—hypertension	3.69e-05	0.000178	CcSEcCtD
Vidarabine—Discomfort—Ramipril—hypertension	3.68e-05	0.000178	CcSEcCtD
Vidarabine—Asthenia—Olmesartan—hypertension	3.68e-05	0.000177	CcSEcCtD
Vidarabine—Dizziness—Nifedipine—hypertension	3.68e-05	0.000177	CcSEcCtD
Vidarabine—Rash—Diltiazem—hypertension	3.67e-05	0.000177	CcSEcCtD
Vidarabine—Rash—Indapamide—hypertension	3.67e-05	0.000177	CcSEcCtD
Vidarabine—Dermatitis—Diltiazem—hypertension	3.67e-05	0.000177	CcSEcCtD
Vidarabine—Dermatitis—Indapamide—hypertension	3.67e-05	0.000177	CcSEcCtD
Vidarabine—Vomiting—Carvedilol—hypertension	3.67e-05	0.000177	CcSEcCtD
Vidarabine—Dizziness—Verapamil—hypertension	3.66e-05	0.000176	CcSEcCtD
Vidarabine—Pain—Betaxolol—hypertension	3.66e-05	0.000176	CcSEcCtD
Vidarabine—Headache—Diltiazem—hypertension	3.65e-05	0.000176	CcSEcCtD
Vidarabine—Headache—Indapamide—hypertension	3.65e-05	0.000176	CcSEcCtD
Vidarabine—Dry mouth—Ramipril—hypertension	3.64e-05	0.000176	CcSEcCtD
Vidarabine—Chest pain—Timolol—hypertension	3.64e-05	0.000176	CcSEcCtD
Vidarabine—Rash—Carvedilol—hypertension	3.64e-05	0.000175	CcSEcCtD
Vidarabine—Dermatitis—Carvedilol—hypertension	3.63e-05	0.000175	CcSEcCtD
Vidarabine—Anxiety—Timolol—hypertension	3.63e-05	0.000175	CcSEcCtD
Vidarabine—Angioedema—Lisinopril—hypertension	3.63e-05	0.000175	CcSEcCtD
Vidarabine—Vomiting—Doxazosin—hypertension	3.63e-05	0.000175	CcSEcCtD
Vidarabine—Hypersensitivity—Clonidine—hypertension	3.62e-05	0.000174	CcSEcCtD
Vidarabine—Headache—Carvedilol—hypertension	3.61e-05	0.000174	CcSEcCtD
Vidarabine—Discomfort—Timolol—hypertension	3.6e-05	0.000174	CcSEcCtD
Vidarabine—Rash—Doxazosin—hypertension	3.6e-05	0.000173	CcSEcCtD
Vidarabine—Dermatitis—Doxazosin—hypertension	3.59e-05	0.000173	CcSEcCtD
Vidarabine—Vomiting—Fosinopril—hypertension	3.58e-05	0.000173	CcSEcCtD
Vidarabine—Nausea—Propranolol—hypertension	3.57e-05	0.000172	CcSEcCtD
Vidarabine—Anaphylactic shock—Ramipril—hypertension	3.57e-05	0.000172	CcSEcCtD
Vidarabine—Headache—Doxazosin—hypertension	3.57e-05	0.000172	CcSEcCtD
Vidarabine—Dry mouth—Timolol—hypertension	3.56e-05	0.000172	CcSEcCtD
Vidarabine—Pain—Losartan—hypertension	3.56e-05	0.000172	CcSEcCtD
Vidarabine—Syncope—Lisinopril—hypertension	3.56e-05	0.000172	CcSEcCtD
Vidarabine—Vomiting—Eplerenone—hypertension	3.56e-05	0.000172	CcSEcCtD
Vidarabine—Rash—Fosinopril—hypertension	3.55e-05	0.000171	CcSEcCtD
Vidarabine—Dermatitis—Fosinopril—hypertension	3.55e-05	0.000171	CcSEcCtD
Vidarabine—Vomiting—Nifedipine—hypertension	3.53e-05	0.00017	CcSEcCtD
Vidarabine—Rash—Eplerenone—hypertension	3.53e-05	0.00017	CcSEcCtD
Vidarabine—Urticaria—Perindopril—hypertension	3.53e-05	0.00017	CcSEcCtD
Vidarabine—Headache—Fosinopril—hypertension	3.53e-05	0.00017	CcSEcCtD
Vidarabine—Hypersensitivity—Trandolapril—hypertension	3.53e-05	0.00017	CcSEcCtD
Vidarabine—Dermatitis—Eplerenone—hypertension	3.53e-05	0.00017	CcSEcCtD
Vidarabine—Asthenia—Clonidine—hypertension	3.52e-05	0.00017	CcSEcCtD
Vidarabine—Vomiting—Verapamil—hypertension	3.52e-05	0.00017	CcSEcCtD
Vidarabine—Urticaria—Irbesartan—hypertension	3.52e-05	0.00017	CcSEcCtD
Vidarabine—Shock—Ramipril—hypertension	3.51e-05	0.00017	CcSEcCtD
Vidarabine—Hypersensitivity—Enalapril—hypertension	3.51e-05	0.000169	CcSEcCtD
Vidarabine—Palpitations—Lisinopril—hypertension	3.51e-05	0.000169	CcSEcCtD
Vidarabine—Headache—Eplerenone—hypertension	3.51e-05	0.000169	CcSEcCtD
Vidarabine—Rash—Nifedipine—hypertension	3.5e-05	0.000169	CcSEcCtD
Vidarabine—Dermatitis—Nifedipine—hypertension	3.5e-05	0.000169	CcSEcCtD
Vidarabine—Anaphylactic shock—Timolol—hypertension	3.49e-05	0.000168	CcSEcCtD
Vidarabine—Loss of consciousness—Lisinopril—hypertension	3.49e-05	0.000168	CcSEcCtD
Vidarabine—Rash—Verapamil—hypertension	3.49e-05	0.000168	CcSEcCtD
Vidarabine—Urticaria—Hydrochlorothiazide—hypertension	3.49e-05	0.000168	CcSEcCtD
Vidarabine—Tachycardia—Ramipril—hypertension	3.49e-05	0.000168	CcSEcCtD
Vidarabine—Dermatitis—Verapamil—hypertension	3.49e-05	0.000168	CcSEcCtD
Vidarabine—Headache—Nifedipine—hypertension	3.48e-05	0.000168	CcSEcCtD
Vidarabine—Headache—Verapamil—hypertension	3.47e-05	0.000167	CcSEcCtD
Vidarabine—Hypersensitivity—Telmisartan—hypertension	3.47e-05	0.000167	CcSEcCtD
Vidarabine—Cough—Lisinopril—hypertension	3.46e-05	0.000167	CcSEcCtD
Vidarabine—Nausea—Indapamide—hypertension	3.46e-05	0.000167	CcSEcCtD
Vidarabine—Nausea—Diltiazem—hypertension	3.46e-05	0.000167	CcSEcCtD
Vidarabine—Hyperhidrosis—Ramipril—hypertension	3.45e-05	0.000167	CcSEcCtD
Vidarabine—Asthenia—Trandolapril—hypertension	3.44e-05	0.000166	CcSEcCtD
Vidarabine—Shock—Timolol—hypertension	3.44e-05	0.000166	CcSEcCtD
Vidarabine—Urticaria—Furosemide—hypertension	3.43e-05	0.000165	CcSEcCtD
Vidarabine—Nausea—Carvedilol—hypertension	3.42e-05	0.000165	CcSEcCtD
Vidarabine—Asthenia—Enalapril—hypertension	3.42e-05	0.000165	CcSEcCtD
Vidarabine—Dizziness—Valsartan—hypertension	3.41e-05	0.000164	CcSEcCtD
Vidarabine—Urticaria—Betaxolol—hypertension	3.4e-05	0.000164	CcSEcCtD
Vidarabine—Dizziness—Olmesartan—hypertension	3.39e-05	0.000163	CcSEcCtD
Vidarabine—Nausea—Doxazosin—hypertension	3.39e-05	0.000163	CcSEcCtD
Vidarabine—Chest pain—Lisinopril—hypertension	3.38e-05	0.000163	CcSEcCtD
Vidarabine—Hyperhidrosis—Timolol—hypertension	3.38e-05	0.000163	CcSEcCtD
Vidarabine—Asthenia—Telmisartan—hypertension	3.38e-05	0.000163	CcSEcCtD
Vidarabine—Anxiety—Lisinopril—hypertension	3.37e-05	0.000162	CcSEcCtD
Vidarabine—Nausea—Fosinopril—hypertension	3.35e-05	0.000161	CcSEcCtD
Vidarabine—Discomfort—Lisinopril—hypertension	3.34e-05	0.000161	CcSEcCtD
Vidarabine—Hypotension—Ramipril—hypertension	3.34e-05	0.000161	CcSEcCtD
Vidarabine—Nausea—Eplerenone—hypertension	3.33e-05	0.00016	CcSEcCtD
Vidarabine—Urticaria—Losartan—hypertension	3.31e-05	0.00016	CcSEcCtD
Vidarabine—Dry mouth—Lisinopril—hypertension	3.31e-05	0.000159	CcSEcCtD
Vidarabine—Nausea—Nifedipine—hypertension	3.3e-05	0.000159	CcSEcCtD
Vidarabine—Nausea—Verapamil—hypertension	3.29e-05	0.000159	CcSEcCtD
Vidarabine—Asthenia—Captopril—hypertension	3.28e-05	0.000158	CcSEcCtD
Vidarabine—Vomiting—Valsartan—hypertension	3.28e-05	0.000158	CcSEcCtD
Vidarabine—Hypotension—Timolol—hypertension	3.26e-05	0.000157	CcSEcCtD
Vidarabine—Hypersensitivity—Irbesartan—hypertension	3.26e-05	0.000157	CcSEcCtD
Vidarabine—Vomiting—Olmesartan—hypertension	3.26e-05	0.000157	CcSEcCtD
Vidarabine—Musculoskeletal discomfort—Ramipril—hypertension	3.25e-05	0.000157	CcSEcCtD
Vidarabine—Rash—Valsartan—hypertension	3.25e-05	0.000157	CcSEcCtD
Vidarabine—Dizziness—Clonidine—hypertension	3.25e-05	0.000157	CcSEcCtD
Vidarabine—Dermatitis—Valsartan—hypertension	3.25e-05	0.000156	CcSEcCtD
Vidarabine—Anaphylactic shock—Lisinopril—hypertension	3.24e-05	0.000156	CcSEcCtD
Vidarabine—Hypersensitivity—Hydrochlorothiazide—hypertension	3.24e-05	0.000156	CcSEcCtD
Vidarabine—Rash—Olmesartan—hypertension	3.23e-05	0.000156	CcSEcCtD
Vidarabine—Dermatitis—Olmesartan—hypertension	3.23e-05	0.000156	CcSEcCtD
Vidarabine—Headache—Valsartan—hypertension	3.23e-05	0.000156	CcSEcCtD
Vidarabine—Headache—Olmesartan—hypertension	3.21e-05	0.000155	CcSEcCtD
Vidarabine—Paraesthesia—Ramipril—hypertension	3.21e-05	0.000155	CcSEcCtD
Vidarabine—Shock—Lisinopril—hypertension	3.19e-05	0.000154	CcSEcCtD
Vidarabine—Asthenia—Perindopril—hypertension	3.19e-05	0.000154	CcSEcCtD
Vidarabine—Dyspnoea—Ramipril—hypertension	3.19e-05	0.000154	CcSEcCtD
Vidarabine—Musculoskeletal discomfort—Timolol—hypertension	3.18e-05	0.000153	CcSEcCtD
Vidarabine—Hypersensitivity—Furosemide—hypertension	3.18e-05	0.000153	CcSEcCtD
Vidarabine—Asthenia—Irbesartan—hypertension	3.18e-05	0.000153	CcSEcCtD
Vidarabine—Somnolence—Ramipril—hypertension	3.18e-05	0.000153	CcSEcCtD
Vidarabine—Dizziness—Trandolapril—hypertension	3.17e-05	0.000153	CcSEcCtD
Vidarabine—Tachycardia—Lisinopril—hypertension	3.16e-05	0.000152	CcSEcCtD
Vidarabine—Dizziness—Enalapril—hypertension	3.15e-05	0.000152	CcSEcCtD
Vidarabine—Asthenia—Hydrochlorothiazide—hypertension	3.15e-05	0.000152	CcSEcCtD
Vidarabine—Hypersensitivity—Betaxolol—hypertension	3.15e-05	0.000152	CcSEcCtD
Vidarabine—Paraesthesia—Timolol—hypertension	3.14e-05	0.000151	CcSEcCtD
Vidarabine—Hyperhidrosis—Lisinopril—hypertension	3.13e-05	0.000151	CcSEcCtD
Vidarabine—Vomiting—Clonidine—hypertension	3.12e-05	0.000151	CcSEcCtD
Vidarabine—Dyspnoea—Timolol—hypertension	3.11e-05	0.00015	CcSEcCtD
Vidarabine—Dizziness—Telmisartan—hypertension	3.11e-05	0.00015	CcSEcCtD
Vidarabine—Somnolence—Timolol—hypertension	3.1e-05	0.00015	CcSEcCtD
Vidarabine—Asthenia—Furosemide—hypertension	3.1e-05	0.000149	CcSEcCtD
Vidarabine—Rash—Clonidine—hypertension	3.1e-05	0.000149	CcSEcCtD
Vidarabine—Dermatitis—Clonidine—hypertension	3.09e-05	0.000149	CcSEcCtD
Vidarabine—Headache—Clonidine—hypertension	3.08e-05	0.000148	CcSEcCtD
Vidarabine—Hypersensitivity—Losartan—hypertension	3.07e-05	0.000148	CcSEcCtD
Vidarabine—Asthenia—Betaxolol—hypertension	3.07e-05	0.000148	CcSEcCtD
Vidarabine—Nausea—Valsartan—hypertension	3.06e-05	0.000148	CcSEcCtD
Vidarabine—Nausea—Olmesartan—hypertension	3.05e-05	0.000147	CcSEcCtD
Vidarabine—Vomiting—Trandolapril—hypertension	3.05e-05	0.000147	CcSEcCtD
Vidarabine—Vomiting—Enalapril—hypertension	3.03e-05	0.000146	CcSEcCtD
Vidarabine—Hypotension—Lisinopril—hypertension	3.03e-05	0.000146	CcSEcCtD
Vidarabine—Dizziness—Captopril—hypertension	3.03e-05	0.000146	CcSEcCtD
Vidarabine—Rash—Trandolapril—hypertension	3.02e-05	0.000146	CcSEcCtD
Vidarabine—Dermatitis—Trandolapril—hypertension	3.02e-05	0.000145	CcSEcCtD
Vidarabine—Rash—Enalapril—hypertension	3.01e-05	0.000145	CcSEcCtD
Vidarabine—Dermatitis—Enalapril—hypertension	3e-05	0.000145	CcSEcCtD
Vidarabine—Headache—Trandolapril—hypertension	3e-05	0.000145	CcSEcCtD
Vidarabine—Vomiting—Telmisartan—hypertension	2.99e-05	0.000144	CcSEcCtD
Vidarabine—Asthenia—Losartan—hypertension	2.99e-05	0.000144	CcSEcCtD
Vidarabine—Headache—Enalapril—hypertension	2.99e-05	0.000144	CcSEcCtD
Vidarabine—Pain—Timolol—hypertension	2.99e-05	0.000144	CcSEcCtD
Vidarabine—Rash—Telmisartan—hypertension	2.97e-05	0.000143	CcSEcCtD
Vidarabine—Dermatitis—Telmisartan—hypertension	2.96e-05	0.000143	CcSEcCtD
Vidarabine—Musculoskeletal discomfort—Lisinopril—hypertension	2.95e-05	0.000142	CcSEcCtD
Vidarabine—Headache—Telmisartan—hypertension	2.95e-05	0.000142	CcSEcCtD
Vidarabine—Dizziness—Perindopril—hypertension	2.94e-05	0.000142	CcSEcCtD
Vidarabine—Dizziness—Irbesartan—hypertension	2.93e-05	0.000141	CcSEcCtD
Vidarabine—Nausea—Clonidine—hypertension	2.92e-05	0.000141	CcSEcCtD
Vidarabine—Paraesthesia—Lisinopril—hypertension	2.91e-05	0.00014	CcSEcCtD
Vidarabine—Vomiting—Captopril—hypertension	2.91e-05	0.00014	CcSEcCtD
Vidarabine—Dizziness—Hydrochlorothiazide—hypertension	2.9e-05	0.00014	CcSEcCtD
Vidarabine—Dyspnoea—Lisinopril—hypertension	2.89e-05	0.000139	CcSEcCtD
Vidarabine—Rash—Captopril—hypertension	2.88e-05	0.000139	CcSEcCtD
Vidarabine—Dermatitis—Captopril—hypertension	2.88e-05	0.000139	CcSEcCtD
Vidarabine—Somnolence—Lisinopril—hypertension	2.88e-05	0.000139	CcSEcCtD
Vidarabine—Headache—Captopril—hypertension	2.87e-05	0.000138	CcSEcCtD
Vidarabine—Dizziness—Furosemide—hypertension	2.86e-05	0.000138	CcSEcCtD
Vidarabine—Nausea—Trandolapril—hypertension	2.84e-05	0.000137	CcSEcCtD
Vidarabine—Urticaria—Ramipril—hypertension	2.84e-05	0.000137	CcSEcCtD
Vidarabine—Nausea—Enalapril—hypertension	2.83e-05	0.000137	CcSEcCtD
Vidarabine—Dizziness—Betaxolol—hypertension	2.83e-05	0.000136	CcSEcCtD
Vidarabine—Vomiting—Perindopril—hypertension	2.82e-05	0.000136	CcSEcCtD
Vidarabine—Vomiting—Irbesartan—hypertension	2.81e-05	0.000136	CcSEcCtD
Vidarabine—Rash—Perindopril—hypertension	2.8e-05	0.000135	CcSEcCtD
Vidarabine—Dermatitis—Perindopril—hypertension	2.8e-05	0.000135	CcSEcCtD
Vidarabine—Nausea—Telmisartan—hypertension	2.79e-05	0.000135	CcSEcCtD
Vidarabine—Vomiting—Hydrochlorothiazide—hypertension	2.79e-05	0.000135	CcSEcCtD
Vidarabine—Rash—Irbesartan—hypertension	2.79e-05	0.000135	CcSEcCtD
Vidarabine—Dermatitis—Irbesartan—hypertension	2.79e-05	0.000134	CcSEcCtD
Vidarabine—Headache—Perindopril—hypertension	2.78e-05	0.000134	CcSEcCtD
Vidarabine—Urticaria—Timolol—hypertension	2.77e-05	0.000134	CcSEcCtD
Vidarabine—Headache—Irbesartan—hypertension	2.77e-05	0.000134	CcSEcCtD
Vidarabine—Pain—Lisinopril—hypertension	2.77e-05	0.000134	CcSEcCtD
Vidarabine—Rash—Hydrochlorothiazide—hypertension	2.77e-05	0.000134	CcSEcCtD
Vidarabine—Dermatitis—Hydrochlorothiazide—hypertension	2.77e-05	0.000133	CcSEcCtD
Vidarabine—Dizziness—Losartan—hypertension	2.76e-05	0.000133	CcSEcCtD
Vidarabine—Headache—Hydrochlorothiazide—hypertension	2.75e-05	0.000133	CcSEcCtD
Vidarabine—Vomiting—Furosemide—hypertension	2.75e-05	0.000132	CcSEcCtD
Vidarabine—Rash—Furosemide—hypertension	2.72e-05	0.000131	CcSEcCtD
Vidarabine—Dermatitis—Furosemide—hypertension	2.72e-05	0.000131	CcSEcCtD
Vidarabine—Vomiting—Betaxolol—hypertension	2.72e-05	0.000131	CcSEcCtD
Vidarabine—Nausea—Captopril—hypertension	2.72e-05	0.000131	CcSEcCtD
Vidarabine—Headache—Furosemide—hypertension	2.71e-05	0.00013	CcSEcCtD
Vidarabine—Rash—Betaxolol—hypertension	2.7e-05	0.00013	CcSEcCtD
Vidarabine—Dermatitis—Betaxolol—hypertension	2.69e-05	0.00013	CcSEcCtD
Vidarabine—Headache—Betaxolol—hypertension	2.68e-05	0.000129	CcSEcCtD
Vidarabine—Vomiting—Losartan—hypertension	2.65e-05	0.000128	CcSEcCtD
Vidarabine—Nausea—Perindopril—hypertension	2.64e-05	0.000127	CcSEcCtD
Vidarabine—Hypersensitivity—Ramipril—hypertension	2.63e-05	0.000127	CcSEcCtD
Vidarabine—Nausea—Irbesartan—hypertension	2.63e-05	0.000127	CcSEcCtD
Vidarabine—Rash—Losartan—hypertension	2.63e-05	0.000127	CcSEcCtD
Vidarabine—Dermatitis—Losartan—hypertension	2.62e-05	0.000127	CcSEcCtD
Vidarabine—Headache—Losartan—hypertension	2.61e-05	0.000126	CcSEcCtD
Vidarabine—Nausea—Hydrochlorothiazide—hypertension	2.61e-05	0.000126	CcSEcCtD
Vidarabine—Urticaria—Lisinopril—hypertension	2.57e-05	0.000124	CcSEcCtD
Vidarabine—Hypersensitivity—Timolol—hypertension	2.57e-05	0.000124	CcSEcCtD
Vidarabine—Nausea—Furosemide—hypertension	2.56e-05	0.000124	CcSEcCtD
Vidarabine—Asthenia—Ramipril—hypertension	2.56e-05	0.000124	CcSEcCtD
Vidarabine—Nausea—Betaxolol—hypertension	2.54e-05	0.000122	CcSEcCtD
Vidarabine—Asthenia—Timolol—hypertension	2.51e-05	0.000121	CcSEcCtD
Vidarabine—Nausea—Losartan—hypertension	2.47e-05	0.000119	CcSEcCtD
Vidarabine—Hypersensitivity—Lisinopril—hypertension	2.39e-05	0.000115	CcSEcCtD
Vidarabine—Dizziness—Ramipril—hypertension	2.36e-05	0.000114	CcSEcCtD
Vidarabine—Asthenia—Lisinopril—hypertension	2.32e-05	0.000112	CcSEcCtD
Vidarabine—Dizziness—Timolol—hypertension	2.31e-05	0.000111	CcSEcCtD
Vidarabine—Vomiting—Ramipril—hypertension	2.27e-05	0.00011	CcSEcCtD
Vidarabine—Rash—Ramipril—hypertension	2.25e-05	0.000109	CcSEcCtD
Vidarabine—Dermatitis—Ramipril—hypertension	2.25e-05	0.000109	CcSEcCtD
Vidarabine—Headache—Ramipril—hypertension	2.24e-05	0.000108	CcSEcCtD
Vidarabine—Vomiting—Timolol—hypertension	2.22e-05	0.000107	CcSEcCtD
Vidarabine—Rash—Timolol—hypertension	2.2e-05	0.000106	CcSEcCtD
Vidarabine—Dermatitis—Timolol—hypertension	2.2e-05	0.000106	CcSEcCtD
Vidarabine—Headache—Timolol—hypertension	2.19e-05	0.000106	CcSEcCtD
Vidarabine—Dizziness—Lisinopril—hypertension	2.14e-05	0.000103	CcSEcCtD
Vidarabine—Nausea—Ramipril—hypertension	2.12e-05	0.000102	CcSEcCtD
Vidarabine—Nausea—Timolol—hypertension	2.07e-05	0.0001	CcSEcCtD
Vidarabine—Vomiting—Lisinopril—hypertension	2.06e-05	9.93e-05	CcSEcCtD
Vidarabine—Rash—Lisinopril—hypertension	2.04e-05	9.85e-05	CcSEcCtD
Vidarabine—Dermatitis—Lisinopril—hypertension	2.04e-05	9.84e-05	CcSEcCtD
Vidarabine—Headache—Lisinopril—hypertension	2.03e-05	9.79e-05	CcSEcCtD
Vidarabine—Nausea—Lisinopril—hypertension	1.92e-05	9.28e-05	CcSEcCtD
Vidarabine—ADK—Metabolism—PPARG—hypertension	1.91e-05	0.00021	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—CNR1—hypertension	1.91e-05	0.000209	CbGpPWpGaD
Vidarabine—ADA—Metabolism—GNAS—hypertension	1.9e-05	0.000209	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—ARHGDIA—hypertension	1.89e-05	0.000208	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—ADRA1A—hypertension	1.89e-05	0.000208	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—INHBA—hypertension	1.89e-05	0.000208	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—CXCL10—hypertension	1.89e-05	0.000208	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—CALM2—hypertension	1.89e-05	0.000207	CbGpPWpGaD
Vidarabine—ADK—Metabolism—POMC—hypertension	1.88e-05	0.000207	CbGpPWpGaD
Vidarabine—ADK—Metabolism—INS—hypertension	1.87e-05	0.000206	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—ROCK2—hypertension	1.87e-05	0.000205	CbGpPWpGaD
Vidarabine—ADA—Metabolism—APOB—hypertension	1.86e-05	0.000204	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—DRD2—hypertension	1.86e-05	0.000204	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—HTR7—hypertension	1.86e-05	0.000204	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—SRC—hypertension	1.85e-05	0.000203	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—GCG—hypertension	1.84e-05	0.000202	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—ADRB2—hypertension	1.84e-05	0.000202	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CYSLTR1—hypertension	1.82e-05	0.0002	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—AVPR1A—hypertension	1.82e-05	0.0002	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—PRKCE—hypertension	1.81e-05	0.000199	CbGpPWpGaD
Vidarabine—ADA—Metabolism—GSTM1—hypertension	1.81e-05	0.000199	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—LHB—hypertension	1.8e-05	0.000198	CbGpPWpGaD
Vidarabine—ADORA2A—Circadian rythm related genes—TP53—hypertension	1.8e-05	0.000198	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—VAV3—hypertension	1.79e-05	0.000197	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—RGS2—hypertension	1.78e-05	0.000196	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—GAL—hypertension	1.78e-05	0.000196	CbGpPWpGaD
Vidarabine—ADA—Metabolism—LPL—hypertension	1.78e-05	0.000195	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—KNG1—hypertension	1.77e-05	0.000194	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—UTS2—hypertension	1.76e-05	0.000193	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—TRH—hypertension	1.76e-05	0.000193	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—GNRH1—hypertension	1.76e-05	0.000193	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CRHR1—hypertension	1.76e-05	0.000193	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CMA1—hypertension	1.76e-05	0.000193	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—VIP—hypertension	1.76e-05	0.000193	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—AGTR1—hypertension	1.76e-05	0.000193	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—GNB3—hypertension	1.75e-05	0.000192	CbGpPWpGaD
Vidarabine—ADA—Metabolism—ADCY5—hypertension	1.74e-05	0.000191	CbGpPWpGaD
Vidarabine—ADA—Metabolism—GPX1—hypertension	1.73e-05	0.00019	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—AVP—hypertension	1.72e-05	0.000189	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—CXCL10—hypertension	1.72e-05	0.000189	CbGpPWpGaD
Vidarabine—ADA—Metabolism—CYP1A1—hypertension	1.72e-05	0.000189	CbGpPWpGaD
Vidarabine—ADK—Metabolism—ALB—hypertension	1.72e-05	0.000189	CbGpPWpGaD
Vidarabine—ADA—Metabolism—PRKCA—hypertension	1.72e-05	0.000189	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—OXTR—hypertension	1.71e-05	0.000187	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—GNAS—hypertension	1.7e-05	0.000187	CbGpPWpGaD
Vidarabine—ADA—Metabolism—CD36—hypertension	1.69e-05	0.000185	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—TRPC3—hypertension	1.69e-05	0.000185	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CX3CR1—hypertension	1.69e-05	0.000185	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CASR—hypertension	1.69e-05	0.000185	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—LRP2—hypertension	1.69e-05	0.000185	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—ADRB2—hypertension	1.67e-05	0.000183	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—BDKRB1—hypertension	1.66e-05	0.000182	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CX3CL1—hypertension	1.66e-05	0.000182	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—HDAC6—hypertension	1.66e-05	0.000182	CbGpPWpGaD
Vidarabine—ADORA2A—Circadian rythm related genes—IL6—hypertension	1.65e-05	0.000181	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—PRKCE—hypertension	1.65e-05	0.000181	CbGpPWpGaD
Vidarabine—ADK—Metabolism—PIK3R1—hypertension	1.64e-05	0.00018	CbGpPWpGaD
Vidarabine—ADK—Metabolism—NOS3—hypertension	1.64e-05	0.00018	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—EDN1—hypertension	1.64e-05	0.00018	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—CCL5—hypertension	1.63e-05	0.000179	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—VAV3—hypertension	1.63e-05	0.000178	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—HSPG2—hypertension	1.63e-05	0.000178	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—EGFR—hypertension	1.62e-05	0.000178	CbGpPWpGaD
Vidarabine—ADORA2A—NGF signalling via TRKA from the plasma membrane—IL6—hypertension	1.62e-05	0.000178	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—PRKG1—hypertension	1.61e-05	0.000177	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—PDE4D—hypertension	1.61e-05	0.000177	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—ADM—hypertension	1.61e-05	0.000177	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—PTH—hypertension	1.61e-05	0.000177	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—GABBR1—hypertension	1.61e-05	0.000177	CbGpPWpGaD
Vidarabine—ADA—Metabolism—MTHFR—hypertension	1.6e-05	0.000176	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—GNB3—hypertension	1.59e-05	0.000174	CbGpPWpGaD
Vidarabine—ADA—Metabolism—PPARA—hypertension	1.57e-05	0.000172	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CYBB—hypertension	1.57e-05	0.000172	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—GLP1R—hypertension	1.57e-05	0.000172	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—TACR1—hypertension	1.57e-05	0.000172	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR ligand binding—CXCL8—hypertension	1.57e-05	0.000172	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—AVP—hypertension	1.57e-05	0.000172	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—ADCY5—hypertension	1.56e-05	0.000171	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—PRKCG—hypertension	1.55e-05	0.00017	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—GNAS—hypertension	1.55e-05	0.00017	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—HRH3—hypertension	1.54e-05	0.00017	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—PRKCA—hypertension	1.54e-05	0.000169	CbGpPWpGaD
Vidarabine—ADA—Metabolism—AGT—hypertension	1.52e-05	0.000167	CbGpPWpGaD
Vidarabine—ADK—Metabolism—PTGS2—hypertension	1.5e-05	0.000165	CbGpPWpGaD
Vidarabine—ADA—Metabolism—CALM1—hypertension	1.5e-05	0.000164	CbGpPWpGaD
Vidarabine—ADORA2A—NGF signalling via TRKA from the plasma membrane—AKT1—hypertension	1.49e-05	0.000164	CbGpPWpGaD
Vidarabine—ADA—Metabolism—APOE—hypertension	1.49e-05	0.000164	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—EDN1—hypertension	1.49e-05	0.000164	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—CCL5—hypertension	1.48e-05	0.000162	CbGpPWpGaD
Vidarabine—ADA—Metabolism—CAV1—hypertension	1.48e-05	0.000162	CbGpPWpGaD
Vidarabine—ADA—Metabolism—APOA1—hypertension	1.47e-05	0.000162	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—PRKCD—hypertension	1.47e-05	0.000161	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—CCR5—hypertension	1.47e-05	0.000161	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—NCF2—hypertension	1.44e-05	0.000158	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—HTR2A—hypertension	1.44e-05	0.000158	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—C3—hypertension	1.43e-05	0.000157	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—ADCY5—hypertension	1.42e-05	0.000155	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—PRKCG—hypertension	1.41e-05	0.000154	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—NPY—hypertension	1.4e-05	0.000154	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—VWF—hypertension	1.4e-05	0.000154	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—PRKCA—hypertension	1.4e-05	0.000153	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—AGT—hypertension	1.36e-05	0.00015	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—OXT—hypertension	1.35e-05	0.000148	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—AGTR2—hypertension	1.35e-05	0.000148	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—HTR1B—hypertension	1.35e-05	0.000148	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CXCL2—hypertension	1.35e-05	0.000148	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—F2R—hypertension	1.33e-05	0.000147	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—TGFBR1—hypertension	1.33e-05	0.000147	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—CCR5—hypertension	1.33e-05	0.000146	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—PRKCD—hypertension	1.33e-05	0.000146	CbGpPWpGaD
Vidarabine—ADK—Metabolism—PTEN—hypertension	1.31e-05	0.000144	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—HTR2A—hypertension	1.3e-05	0.000143	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—C3—hypertension	1.3e-05	0.000143	CbGpPWpGaD
Vidarabine—ADA—Metabolism—PPARG—hypertension	1.3e-05	0.000143	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—EDNRB—hypertension	1.29e-05	0.000142	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—NCF1—hypertension	1.29e-05	0.000142	CbGpPWpGaD
Vidarabine—ADA—Metabolism—POMC—hypertension	1.28e-05	0.000141	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—TAC1—hypertension	1.28e-05	0.000141	CbGpPWpGaD
Vidarabine—ADA—Metabolism—INS—hypertension	1.27e-05	0.00014	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—F2—hypertension	1.26e-05	0.000138	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—PRKCB—hypertension	1.26e-05	0.000138	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—ANXA1—hypertension	1.26e-05	0.000138	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CXCR3—hypertension	1.26e-05	0.000138	CbGpPWpGaD
Vidarabine—ADK—Metabolism—EP300—hypertension	1.25e-05	0.000137	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—IL6—hypertension	1.24e-05	0.000137	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—IKBKB—hypertension	1.24e-05	0.000136	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—AGT—hypertension	1.24e-05	0.000136	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—EDNRA—hypertension	1.22e-05	0.000134	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—SST—hypertension	1.22e-05	0.000134	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—CALM1—hypertension	1.22e-05	0.000133	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—DRD3—hypertension	1.22e-05	0.000133	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CYBA—hypertension	1.22e-05	0.000133	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—ADRB1—hypertension	1.22e-05	0.000133	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—FLT1—hypertension	1.22e-05	0.000133	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—ADRA2A—hypertension	1.19e-05	0.000131	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—PLAT—hypertension	1.19e-05	0.000131	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—GHRL—hypertension	1.19e-05	0.000131	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CALCA—hypertension	1.18e-05	0.000129	CbGpPWpGaD
Vidarabine—ADA—Metabolism—ALB—hypertension	1.17e-05	0.000128	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—BDKRB2—hypertension	1.15e-05	0.000126	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—AKT1—hypertension	1.15e-05	0.000126	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—POMC—hypertension	1.15e-05	0.000126	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—PRKCB—hypertension	1.14e-05	0.000125	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—F2—hypertension	1.14e-05	0.000125	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—ADRBK1—hypertension	1.13e-05	0.000125	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CNR1—hypertension	1.13e-05	0.000124	CbGpPWpGaD
Vidarabine—ADA—Metabolism—NOS3—hypertension	1.12e-05	0.000123	CbGpPWpGaD
Vidarabine—ADA—Metabolism—PIK3R1—hypertension	1.12e-05	0.000123	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CALM2—hypertension	1.11e-05	0.000122	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—AKT2—hypertension	1.1e-05	0.000121	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—HTR7—hypertension	1.1e-05	0.000121	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—DRD2—hypertension	1.1e-05	0.000121	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—GCG—hypertension	1.09e-05	0.000119	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—PTPN1—hypertension	1.09e-05	0.000119	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—KL—hypertension	1.07e-05	0.000117	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—NOTCH2—hypertension	1.07e-05	0.000117	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—ITGAV—hypertension	1.05e-05	0.000115	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—NGFR—hypertension	1.05e-05	0.000115	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—KNG1—hypertension	1.04e-05	0.000115	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—POMC—hypertension	1.04e-05	0.000114	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—PRL—hypertension	1.04e-05	0.000114	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—AGTR1—hypertension	1.04e-05	0.000114	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—STK11—hypertension	1.02e-05	0.000112	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—HDAC1—hypertension	1.02e-05	0.000112	CbGpPWpGaD
Vidarabine—ADA—Metabolism—PTGS2—hypertension	1.02e-05	0.000112	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—CCL2—hypertension	1.02e-05	0.000112	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CXCL10—hypertension	1.01e-05	0.000111	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—PLG—hypertension	1.01e-05	0.000111	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—RHOA—hypertension	1.01e-05	0.000111	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—AKT2—hypertension	1e-05	0.00011	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—PIK3R1—hypertension	1e-05	0.00011	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—ADRB2—hypertension	9.85e-06	0.000108	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—PRKCE—hypertension	9.72e-06	0.000107	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—PDGFA—hypertension	9.6e-06	0.000105	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—VAV3—hypertension	9.6e-06	0.000105	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—TGFBR2—hypertension	9.47e-06	0.000104	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—GNB3—hypertension	9.38e-06	0.000103	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—AVP—hypertension	9.25e-06	0.000102	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—RHOA—hypertension	9.17e-06	0.000101	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—GNAS—hypertension	9.13e-06	0.0001	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—PIK3R1—hypertension	9.08e-06	9.97e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—APOB—hypertension	8.94e-06	9.82e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—PTK2—hypertension	8.91e-06	9.78e-05	CbGpPWpGaD
Vidarabine—ADA—Metabolism—PTEN—hypertension	8.91e-06	9.78e-05	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—CXCL8—hypertension	8.87e-06	9.73e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—EDN1—hypertension	8.8e-06	9.66e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CCL5—hypertension	8.73e-06	9.59e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—LPL—hypertension	8.54e-06	9.37e-05	CbGpPWpGaD
Vidarabine—ADA—Metabolism—EP300—hypertension	8.49e-06	9.32e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—H2AFX—hypertension	8.48e-06	9.31e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—RPS6KB1—hypertension	8.46e-06	9.29e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—PDGFRB—hypertension	8.46e-06	9.29e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—ADCY5—hypertension	8.36e-06	9.18e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—PRKCG—hypertension	8.3e-06	9.12e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—ITGB3—hypertension	8.25e-06	9.05e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—PRKCA—hypertension	8.25e-06	9.05e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—YWHAZ—hypertension	8.18e-06	8.98e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—NGF—hypertension	8.09e-06	8.88e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—SPP1—hypertension	8.09e-06	8.88e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—CXCL8—hypertension	8.05e-06	8.84e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—PRKCD—hypertension	7.87e-06	8.64e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CCR5—hypertension	7.87e-06	8.64e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—HTR2A—hypertension	7.7e-06	8.45e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—C3—hypertension	7.69e-06	8.44e-05	CbGpPWpGaD
Vidarabine—ADK—Metabolism—AKT1—hypertension	7.55e-06	8.29e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—PDGFB—hypertension	7.48e-06	8.22e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—FGFR1—hypertension	7.44e-06	8.17e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—HIF1A—hypertension	7.33e-06	8.05e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—AGT—hypertension	7.3e-06	8.02e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CALM1—hypertension	7.18e-06	7.89e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—APOE—hypertension	7.16e-06	7.86e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—LEP—hypertension	7.16e-06	7.86e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CAV1—hypertension	7.09e-06	7.79e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—APOA1—hypertension	7.08e-06	7.77e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—KDR—hypertension	7.01e-06	7.7e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—FN1—hypertension	6.75e-06	7.41e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—F2—hypertension	6.75e-06	7.41e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—PRKCB—hypertension	6.75e-06	7.41e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—NOTCH1—hypertension	6.61e-06	7.25e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—POMC—hypertension	6.15e-06	6.75e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—INS—hypertension	6.11e-06	6.71e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CCL2—hypertension	6.02e-06	6.61e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—IGF1—hypertension	5.91e-06	6.49e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—AKT2—hypertension	5.91e-06	6.49e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—EGFR—hypertension	5.89e-06	6.46e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—SERPINE1—hypertension	5.62e-06	6.17e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—FGF2—hypertension	5.44e-06	5.97e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—RHOA—hypertension	5.42e-06	5.95e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—PIK3R1—hypertension	5.36e-06	5.89e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—NOS3—hypertension	5.36e-06	5.89e-05	CbGpPWpGaD
Vidarabine—ADA—Metabolism—AKT1—hypertension	5.13e-06	5.63e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—RELA—hypertension	5.05e-06	5.54e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—MTOR—hypertension	4.95e-06	5.43e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CXCL8—hypertension	4.76e-06	5.22e-05	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—AKT1—hypertension	4.59e-06	5.04e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—IL6—hypertension	4.52e-06	4.97e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—MMP9—hypertension	4.3e-06	4.72e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CDKN1A—hypertension	4.29e-06	4.71e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—PTEN—hypertension	4.28e-06	4.7e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—MAPK8—hypertension	4.18e-06	4.59e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—AKT1—hypertension	4.17e-06	4.58e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—EP300—hypertension	4.08e-06	4.48e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—SRC—hypertension	3.97e-06	4.35e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—VEGFA—hypertension	3.86e-06	4.24e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—MYC—hypertension	3.55e-06	3.9e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—TGFB1—hypertension	3.55e-06	3.89e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—EGFR—hypertension	3.48e-06	3.82e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—TP53—hypertension	2.92e-06	3.2e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—IL6—hypertension	2.67e-06	2.93e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—AKT1—hypertension	2.46e-06	2.71e-05	CbGpPWpGaD
